White panel
 

Company News

 

BIOSPECTRA TO PRESENT AT EXCIPIENTFEST 2017

https://biospectra.us/excipientfest.html

EXECUTIVE INTERVIEW: Rick Mutchler, CEO

http://www.drug-dev.com/Main/Back-Issues/763.aspx


PRODUCT SUITABILITY: Dora Meissner, Regulatory Manager

http://www.pharmtech.com/product-suitability-intended-end-use


API UREA NOW AVAILABLE FROM FDA REGISTERED FACILITY

http://www.drug-dev.com/Main/Current-News/1112.aspx


NEW CONTRACT MANUFACTURING FACILITY

http://www.pharmtech.com/biospectra-opens-contract-manufacturing-facility


HEPES, MOPS & MES/Secure Supply Chain

http://drug-dev.com/Main/Current-News/cGMP-HEPES-MOPS-MES-Available-With-Full-Traceabili-1023.aspx


INDUSTRY LEADING CUSTOM MANUFACTURING CAPABILITIES

http://www.drug-dev.com/Main/Technology-Showcase/277.aspx


INDUSTRY LEADING CUSTOM MANUFACTURING CAPABILITIES

http://www.drug-dev.com/Main/Current-News/1086.aspx


PHARMA & BIOPHARMA PRODUCT LAUNCH

http://www.contractpharma.com/contents/view_breaking-news/2014-07-24/biospectra-launches-contract-manufacturing-services/


cGMP ZWITTERIONIC BUFFERS

http://www.drug-dev.com/Main/Technology-Showcase/268.aspx